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Abstract
Background: Ribonuclease 8 is a member of the RNase A family of secretory ribonucleases; orthologs of this gene
have been found only in primate genomes. RNase 8 is a divergent paralog of RNase 7, which is lysine-enriched,
highly conserved, has prominent antimicrobial activity, and is expressed in both normal and diseased skin; in
contrast, the physiologic function of RNase 8 remains uncertain. Here, we examine the genetic diversity of human
RNase 8, a subject of significant interest given the existence of functional pseudogenes (coding sequences that are
otherwise intact but with mutations in elements crucial for ribonucleolytic activity) in non-human primate
genomes.
Results: RNase 8 expression was detected in adult human lung, spleen and testis tissue by quantitative reverse-
transcription PCR. Only two single-nucleotide polymorphisms and four unique alleles were identified within the
RNase 8 coding sequence; nucleotide sequence diversity (π = 0.00122 ± 0.00009 per site) was unremarkable for a
human nuclear gene. We isolated transcripts encoding RNase 8 via rapid amplification of cDNA ends (RACE) and
RT-PCR which included a distal potential translational start site followed by sequence encoding an additional 30
amino acids that are conserved in the genomes of several higher primates. The distal translational start site is
functional and promotes RNase 8 synthesis in transfected COS-7 cells.
Conclusions: These results suggest that RNase 8 may diverge considerably from typical RNase A family
ribonucleases and may likewise exhibit unique function. This finding prompts a reconsideration of what we have
previously termed functional pseudogenes, as RNase 8 may be responding to constraints that promote significant
functional divergence from the canonical structure and enzymatic activity characteristic of the RNase A family.
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Background
RNase A ribonucleases are vertebrate proteins with
unique tertiary structure and specific enzymatic activity
[1,2]. Bovine pancreatic ribonuclease, or RNase A, is the
prototype and founding member of this family, which
includes enzymatically-active proteins from humans,
multiple mammalian species,b i r d s ,a n dv e r t e b r a t ef i s h
[3-5]. Initial publication of the complete sequence of the
human genome led to the discovery of several highly
divergent orthologs of RNase A (RNases 9-13) that
seemed to have lost elements crucial for enzymatic
activity [6,7]. Even among the more prototypical RNase
A ribonucleases, such as eosinophil cationic protein
(RNase 3) and avian leukocyte RNase A-2, ribonuclease
activity is not an essential component of their promi-
nent antimicrobial properties [8,9]. These and related
findings have suggest that active evolutionary constraints
may not be directed toward maintaining optimal levels
of enzymatic activity, and that the RNase A genes them-
selves may actually be serving more as evolutionary scaf-
folds, the genetic raw material for ongoing
diversification [9,10]. Examples of this concept include
the functional compartmentalization of the digestive
ribonucleases RNase 1 and 1B of herbivorous primate,
douc langur [11]; the species-limited duplication of
bovine RNase A leading to bovine seminal RNase [12];
the identification of multiple rodent RNase 1 clusters
[13]; and the dramatic and extensive diversification of
both primate and rodent eosinophil ribonucleases
[14-16].
RNases 7 and 8 are among the more recently discov-
ered of the RNase A ribonucleases. RNase 7 was
described by Harder and Schröeder [17] as an
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Zhang and colleagues [18] who located the RNase 7
open reading frame in the first draft release of the
human genome sequence. RNase 7 is expressed in pri-
mary keratinocytes in response to proinflammatory sti-
muli [17], has dramatic activity against numerous
bacterial and some fungal pathogens [17,19,20], and has
been associated with several cutaneous disease states
[21,22]. In contrast to the arginine-rich antimicrobial
RNases ECP and leukocyte RNase A-2, RNase 7 is catio-
n i cd u et oa na b u n d a n c eo fl y s i n er e s i d u e s .H u a n ga n d
colleagues [23] have shown that multiple lysines interact
with the bacterial membrane to promote antimicrobial
activity; recently, P. aeruginosa outer membrane protein
1 has also been documented as a specific target [24].
RNase 7 coding sequences have been identified in recent
releases of the chimpanzee (P. troglodytes) and macaque
(M. mulatta) genomes, at 99% and 93% encoded amino
acid sequence identities to the human RNase 7, respec-
tively. There is no ortholog of RNase 7 in the mouse
genome.
Human RNase 8 was also identified as an open read-
ing frame in the first release of the human genome
sequence [25]. In our original report, we noted that
RNase 8 was not as cationic as RNase 7, and had an aty-
pical cysteine structure later shown by Zhang [26] to
have evolved by a gain-and-loss, or disulfide shuffling
mechanism. We evaluated RNase 8 sequences from 10
primate species, and found several examples in which
otherwise full length sequences encoded alterations in
elements essential to ribonuclease structure and/or
activity, a feature we termed “functional pseudogenes”
[25]. This finding appears to be unique to RNase 8; no
evidence of functional pseudogenization has emerged in
similar studies of the eosinophil ribonucleases, angio-
genin, or RNase 6 [14,27,28].
Given this unusual pattern of diversification, we ques-
tioned whether we might detect similar pseudogenized
alleles of RNase 8 within the human population. We
explored this possibility by isolating and sequencing
coding alleles from characterized panels of genomic
DNA from diverse human sources. Here we present our
findings on the genetic diversity of human RNase 8.
Equally interesting, we present a novel and previously
unrecognized distal translational start site encoded
within the transcript, which has prompted us to reconsi-
der RNase 8 expression and function.
Results
Expression of RNase 8 in human tissues
Expression of RNase 8 in adult and fetal human tissue
was evaluated by qRT-PCR Figure 1A and 1B using
standard curves for quantitative determination of abso-
lute copy number of both RNase 8 and the expression
control, GAPDH (see Methods). As shown, expression
of RNase 8 (copies/GAPDH) was relatively low in all tis-
sues evaluated. Even at its most abundant, in adult
human spleen, we detected 1 copy of RNase 8 to every
4000 copies of GAPDH; expression in other cells and
tissues was substantially lower. Interestingly, our pre-
vious examination of RNase 8 by Northern analysis sug-
gested that prominent expression was limited to
placental tissue. The reasons underlying the discrepancy
between these two sets of results remains unclear, but
are likely related to methodology. Quantitative RT-PCR
is a more sensitive and specific means for detection of
gene expression. The method featured here has under-
gone careful development and cross-reaction specifically
with human RNase 7 has been ruled out (data not
shown). As the target tissues are from commercial sup-
pliers, and the Northern blot featured in the earlier pub-
lication was utilized for studies carried out nearly ten
years ago [25], it is not possible to do a direct compari-
son at this time.
The coding sequence of human RNase 8 includes two
SNPs and an extended amino terminus
A 462 bp open reading frame including a hydrophobic
sequence (here, nt 94-174) preceding the ribonuclease
domain (nt 115-555) was originally identified in the
human genome as RNase 8 based on its direct sequence
homology with human RNase 7 [25]. In this work, we
re-examined this locus, and we identified an extended
open reading frame which includes a distal translational
start site and a segment encoding an additional 30
amino acids preceding the original amino terminus Fig-
ure 2A. This extended 555 bp open reading frame was
identified in sequences isolated from 27 independent
samples of human genomic DNA, providing 54 unique
alleles for analysis. All alleles encoded complete open
reading frames without frameshift mutations or prema-
ture stop codons. No changes were detected in elements
necessary for enzymatic activity (the H
22 -K
45 -H
129
catalytic triad), although one allele from one individual
included a polymorphism/mutation that resulted in a
C
37 /R (codon T
283 ↔ C). This would be a structurally-
destabilizing mutation in a typical RNase A family ribo-
nuclease; however, given unusual amino terminus
encoded by the complete open reading frame within the
RNase 8 transcript (see below), it is not at all clear what
the impact of this polymorphism might be on its final
conformation.
Two non-silent SNPs were identified within the
extended RNase 8 coding sequence. One SNP (C
86 ↔
T; rs12434982) results in alternating S
-30/L within the
extended amino terminal sequence; the second SNP
(T
121 ↔ C) alters the sequence of the hydrophobic seg-
ment, S
-18 /P (rs12437266; [29]). Other than the
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37/
R), there were no SNPs identified in the ribonuclease
domain of RNase 8. The predominant S
-30S
-18 variant
accounts for 54% of the alleles examined; the remaining
variants constitute 17% (S
-30P
-18), 11% (L
-30S
-18), and
18% (L
-30P
-18) of the total Figure 2B. Nucleotide
sequence diversity was calculated at π = 0.00122 ±
0.00009 per site.
Characterization of the transcripts encoding human
RNase 8
Transcripts encoding RNase 8 were detected in and ampli-
fied from human spleen cDNA using the rapid amplifica-
tion of cDNA ends (RACE) method Figure 3A. The ~800
bp and ~1000 bp sequences amplified the full coding
sequence of RNase 8, including sequence encoding the 5’
amino terminal sequence including the distal start site; no
introns were detected. To confirm the presence of the
amino terminal extension and to rule out the possibility of
genomic contaminants in the commercial cDNA prepara-
tion, we created new 5’® 3’ primers based on cDNA
sequence determined from RACE together with known
3’® 5’ primers Table 1 to carry out nested RT-PCR target-
ing both human placenta and spleen poly A
+ RNA Figures
3B and 3C. This experimental trial (performed with and
without reverse transcriptase) documented expression of
RNase 8 transcript in these tissues and likewise amplified
the full open reading frame including the amino terminal
extension Figure 3C.
Extended amino termini in primate RNase 8s
Extended amino terminal sequences were identified in the
open reading frames of RNase 8s from five higher primate
species Figure 4A. Hydrophobicity score vs. amino acid
position (Kyte-Doolittle plot [30], Figure 4B) indicates that
this segment (amino acids 1-31, note the renumbering in
this figure) is relatively hydrophilic, particularly in compar-
ison to the hydrophobic segment that follows (amino acids
32-55), although the multiple leucine substitutions in the
P. hamadryas and M. mulatta sequences render this
region somewhat less hydrophilic than the featured
human sequence. Overall, however, the presence of this
amino terminal sequence indicates that the encoded
RNase 8 polypeptide may be structurally atypical among
RNase A family members, as this configuration is not one
of a classic secretory mediator (see Discussion).
Characterization of the two translational start sites
As shown in Figure 2, the full-length RNase 8 transcript
encodes both proximal (at amino acid position -27) and
Figure 1 Expression of RNase 8 in adult and fetal human tissues. Copies of RNase 8 transcript per copy of GAPDH (x 10
6) in (A) adult and
(B) fetal tissues. Shown are the mean ± standard deviations of three separate experimental trials performed on pooled cDNAs. Abbreviations
include pancr, pancreas; prost, prostate; sm int, small intestine; leukoc, leukocyte; sk muscle, skeletal muscle.
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Page 3 of 10Figure 2 The coding sequence of human RNase 8 includes two non-silent SNPs and a previously unrecognized 5’ extended open
reading frame. (A) Highlighted in red are SNPs located within the hydrophobic segment previously identified as a signal sequence (in black, in
italics) another within the newly-identified coding segment preceding it (in green, in italics). Highlighted in blue are the amino terminus (K) of
the RNase domain (at the arrow), the eight cysteines and catalytic histidines (H) and lysine (K); stop codon denoted by asterisk (*) and bold text.
(B) Number of independent alleles and percent of total are as shown. GenBank accession numbers for sequences features in this figure are
JQ361124-JQ361128.
Figure 3 Identification and characterization of RNase 8 transcript. (A) ~800 and ~1000 bp transcripts encoding RNase 8 were isolated from
human spleen cDNA using a nested rapid amplification of cDNA ends (RACE); +, including adapter primer;-without adapter primer. (B) Findings
from RACE confirmed by RT-PCR using two unique sources of poly A
+ RNA; +, including reverse transcriptase;-without reverse transcriptase. (C)
RNase 8 on human chromosome 14; black bar, coding sequence originally described [25] green bar, novel amino terminal extension. RACE
amplification products are shown above extending 0.8 and 1 kb from primer within the RNase 8 coding sequence; nested RT-PCR amplification
product (0.5 kb) is also as shown below. The GenBank accession number for the spleen cDNA RNase 8 transcript sequences is JQ353679.
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Page 4 of 10distal (at position -58) translational start sites. The prox-
imal is in a position that is typical for RNase A family
ribonucleases, as it leads what would otherwise be a
hydrophobic signal sequence; its nucleotide sequence is
within a reasonable approximation of a consensus trans-
lation initiation sequence. In contrast, the distal transla-
tional start site is atypical and requires functional
assessment. Toward this end, we utilized one or both
translational start sites to direct synthesis of recombi-
nant RNase 8 in COS-7 cells Figure 5. Quantitative RT-
PCR analysis indicated that all mRNAs were transcribed
and stable in COS-7 cells, with Ct values between 20
and 23 (data not shown). As anticipated, the RNase 8
proximal translational start site viable and active (con-
struct CCC4). The distal start site alone (construct
CCC5) was likewise active. Interestingly, the construct
that directly replicates the configuration of the natural
transcript (CCC3), and includes both the distal and the
proximal translational start sites, promotes expression of
RNase 8 protein over background, albeit at a reduced
level.
Discussion
RNase 8 is closely related to RNase 7, but it is clearly
subject to different evolutionary constraints. RNase 7 is
a prototypical RNase A ribonuclease, as it is enzymati-
cally active against standard RNA substrates, includes an
H -K- H catalytic triad, and eight canonically-spaced
cysteines that generate disulfide bonds that define the
tertiary structure [17,18]. Although no formal evolution-
ary analysis has been performed on the RNase 7 lineage,
a comparison of available coding sequences from human
and genome builds of chimpanzee and macaque [29]
suggests that this lineage is highly conserved over time.
In contrast, in an earlier study of RNase 8, we documen-
ted substantial interspecies divergence (1.3 × 10
-9
Table 1 Amplification, sequencing and site-directed mutagenesis primers for RNase 8
Gene-amplification
RN8F 5’- CAC ATT GCC CTG CAA TAA CTG GCT -3’
RN8R 5’- AGG TTG AGT GTG TGG GAG GGA AAT -3’
Sequencing
RNase 8 Fi 5’- TCA CTC TGT TCC ACT GTC TCC CTT -3’
RNase 8 Ri 5’- AGT CTG CAG AGT GTG AG GTG GAA -3’
Human RNase 8 nested RACE (human spleen cDNA)
rcRN8 (3’ ® 5’)5 ’-CAA CTT TAT CCA AGT GCA CAG GA-3’
R85Rn (3’ ® 5’)5 ’-CTG GGT CAC CCT GTT GTG GAG-3’
Human RNase 8 nested reverse-trancriptase PCR (RT-PCR)
R8S 5’-ACA ATA GAA TGC CAG GGG TGT TCA-3’
R85R 5’-CAA CTT TAT CCA AGT GCA CAG GA-3’
R8Sn 5’-CAT TGC CCT GCA ATA ACT GGC TT-3’
R85Rn 5’-CTG GGT CAC CCT GTT GTG GAG-3’
Human RNase 8 quantitative RT-PCR
RNase 8fx 5’- CAT AGC CTG CAA GAA TAG CTG TAA AA-3’
RNase 8rx 5’- TCA CCC ATG GTC AGG GAC AT-3’
6FAM-RNase 8-TAMRA 6FAM-CTG CCA CCA GAG CCA CGG GC-TAMRA
Nested primate genome RNase 8
5’R8F 5’-GCC AGG GGT GTT CAA TAT CTT AG-3’
3’R8R 5’-AGG TTG AGT GTG TGG GAG GGA AAT-3’
5’R8Fn 5’-CAC ATT GCC CTG CAA TAA CTG GCT-3’
3’R8Fn 5’-AGT CTG CAG AGT GTG AGG TGG AAC-3’
RNase 8 expression plasmids
CCC3
R8D 5’-AAG CTT ATT GCC CTG CAA TAA CTG GCT TAG GGT-3’
R8C 5’-CTC CTC CTC TCT AGA GAC AAC TTT ATC CAA GTG CAC A-3’
CCC4
R8O 5’-AAG CTT ACT CTG TTC CAC TGT CTC CCT TAA GAG AG-3’
R8C 5’-CTC CTC CTC TCT AGA GAC AAC TTT ATC CAA GTG CAC A-3’
CCC5 mutagenesis
R85F 5’-TCT CCC TTA AGA GAG ATA GCA CCG GCC AGA GCA-3’
R85R 5’-TGC TCT GGC CGG TGC TAT CTC TCT TAA GGG AGA-3’
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Page 5 of 10Figure 4 Predicted amino terminal extensions of the RNase 8 coding sequence are conserved in primate genomes. (A) Shown are
coding sequences that incorporate RNase 8 from Build 2.1 of the genome of P. troglodytes and Build 1.1 of M. mulatta and original sequence
data generated from RNase 8 isolated from genomic DNA from P. troglodytes (chimpanzee; JQ353681), P. pygmaeus (orangutan; JQ353682), P.
hamadryas (babooon’ JQ353680), and G. gorilla (gorilla; JQ353683). Amino acids 1-31 are from the extended open reading frame, amino acids 32-
55 (separated by hyphen) are those originally predicted as components of a signal sequence; divergence from the H. sapiens (human) sequence
is indicated in red. (B) Evaluation of the predicted hydrophobicity of the human RNase 8 amino terminus (amino acids 1-55) via the Kyte-
Doolittle algorithm [29].
Figure 5 Evaluation of the distal and proximal translational start sites. (A) COS-7 cells were transfected via the lipofectamine method, and
cells expressing carboxy-terminal-FLAG tagged RNase 8 were detected by flow cytometry. Construct CCC3 includes both distal and proximal
start sites (see Figure 3); constructs CCC4 and CCC5 include the proximal and distal translational start sites only, respectively, and the final panel
is the vector (pcDNA3.1) control alone. IC; rabbit anti-IgG isotype control. (B) Compilation of seven independent experiments; *p < 0.05.
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Page 6 of 10substitutions/site/year), and we noted the existence of
true pseudogenes, with significant truncations in
encoded polypeptides in the genomes of several higher
primates, including gorilla (G. gorilla) and baboon (P.
hamadryas). We also identified RNase 8 functional
pseudogenes; these were genes that encoded full length
RNase 8 polypeptides but with mutations in crucial
structural or catalytic residues [25]. Examples include
RNase 8s from the tamarin (S. oedipus), in which the
first catalytic histidine (H) is mutated to aspartic acid
(D), and likewise the African green monkey (C.
aethiops), in which a structural cysteine is lost. We
embarked on the present study in large part to deter-
mine whether alleles encoding pseudogenes (true or
functional) might be circulating within the human popu-
lation. Interestingly, although detected in only one
human allele among those in our study, we did identify
aC
37/R polymorphism similar to that found in the C.
aethiops gene. Aside from that one isolate, only two
main SNPs were identified within the coding sequence
of RNase 8, and although the nucleotide sequence diver-
sity was somewhat greater than that observed for RNase
7( π = 0.00073 ± 0.00022; unpublished data), the value
calculated for RNase 8, π = 0.00122 ± 0.00009 per site,
is within the normal range for nuclear genes [31], and is
similar to values determined for the functional eosino-
phils RNases, the eosinophil-derived neurotoxin (EDN/
RNase 2; π = 0.00063 ± 0.0001) and eosinophil cationic
protein (ECP/RNase 3; π = 0.00113 ± 0.00006) [32].
However, perhaps most intriguing of all is the elucida-
tion of the distal translational start site and putative
extended open reading frame of RNase 8; the original
start site was identified based on sequence homology to
RNase 7 [25] and other RNase A family ribonucleases.
This amino terminal extension is unique and breaks the
paradigm for the prototypical RNase A ribonucleases,
which, as a group, are granule and/or secretory proteins,
with amino terminal hydrophobic signal sequences that
direct the nascent polypeptides through the ER/Golgi
for post-translational processing prior to release [33]. In
contrast to the hydrophobic quality of amino acids 32 to
58 Figure 5B, the amino terminus that includes amino
acids 1-31, has a predominantly hydrophilic nature. As
such, RNase 8 with this extension may not be a secre-
tory protein. Unfortunately, despite significant effort and
a recently developed specific anti-peptide antibody, we
have been unable to detect expression of RNase 8 poly-
peptide in human fibroblast or hematopoietic cell lines.
This may be due to the fact that expression levels at
homeostasis are quite low Figure 2 and the appropriate
conditions under which expression is augmented are not
yet clear. Consistent with this finding, we have found
that the natural construct, which includes the distal
translational start site in tandem with the proximal
translational start site, promotes only minimally activity
Figure 5. The absence of an RNase 8 ortholog in labora-
tory rodent models adds to the limitations we are
confronting.
Conclusion
Given these observations, taken together with our recent
appreciation of the RNase A ribonuclease genes as scaf-
folds for evolutionary change [9,10], it is apparent that
we need to consider the possibility that RNase 8 is
expressed as something other than a standard secretory
ribonuclease; by extension, we need to revise the con-
cept of functional pseudogenes. It is conceivable that
RNase 8 is under constraints promoting selection of a
novel function, perhaps only partially-related to its origi-
nal role; as such, rigid adherence to the structure that is
required for enzymatic cleavage of polymeric RNA is no
longer necessary or useful. This and related hypotheses
certainly merit further consideration.
Methods
Human genomic DNA samples and sequence analysis
Genomic DNA samples from human lymphocytes were
obtained from the Coriell Institute for Medical Research
(Camden, NJ). Additional samples of genomic DNA
were obtained from normal volunteers after standard
informed consent (protocol NIAID 09-I-0049). Table 1
includes sequences of all amplification, sequencing and
mutagenesis primers. Briefly, 50 ng genomic DNA was
used as an amplification target with 1 unit of Platinum
Taq polymerase under standard conditions. Genomic
DNAs, Taq proofreading polymerase, and gene-specific
primers RN8F and RN8R primers were used to amplify
a 688 bp genomic fragment encompassing the RNase 8
open reading frame. Amplification products were
sequenced in both directions with BigDye terminator
v3.1 on a 3130x Applied BioSystems sequencer using
manufacturer’s specifications. Heterozygosity was con-
firmed and resolved as necessary by cloning amplifica-
tion products into TA vectors and re-sequencing.
Amplification of RNase 8 from primate genomic DNA
Primate genomic DNAs from Pan troglodytes, Gorilla
gorilla, Pongo pygmaeus were obtained from BIOSLabs
(New Haven, CT). Genomic DNA from Papio hama-
dryas was isolated from the 26CB-1 lymphoblast line
(CRL-1495, American Type Culture Collection, Mana-
s s a s ,V A ) .N e s t e dP C Rw a sc a r r i e do u tv i af i r s tr o u n d
amplification using primers 5’-R8F and 3’-R8R; 0.5 μgo f
gDNA and 50X Titanium Taq polymerase were used to
amplify the target gene with the cycling parameters
including 95°C for 1 min followed by 30 cycles, 95°C for
30 sec, then 68°C 1.5 min, and 68°C for 3 min. The sec-
ond nested amplification was performed to generate a ~
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primers 5’-R8Fn and 3’-R8Rn. Amplification products
were cloned into TA 2.1 vector (Invitrogen) and multi-
ple clones were sequenced in both directions using Big-
Dye terminator v3.1 on a 3130x Applied Biosystems
sequencer.
Database search and analysis of genome sequence data
Primate RNase 7 and RNase 8 sequences are located in
the GenBank database under accession numbers
AF473854-AF473863. Extended 5’ coding sequences
were identified in RNase 8s of both P. troglodytes and
M. mulatta upon BLAST search of these full genome
databases (Builds 2.1 and 1.1, respectively) accessed via
the National Center for Bioinformatics (NCBI) website
[29]. Sequence alignments were generated with Clus-
talW [34] and analyzed with algorithms included within
MEGA version 4.0 ([35] and DNAsp [36].
Rapid amplification of cDNA ends (RACE)
0.5 ng of human spleen marathon RACE-ready cDNA
(Clontech) was amplified using the A2 polymerase kit
(Clontech) and a 3’ ® 5’ primer rcRN8 specific for
RNase 8 and primary adapter primer as per manufac-
turer’s instructions. The PCR cycling parameters were as
follows: 94°C for 1 min followed by 40 cycles of 94°C for
30 sec and then 62°C for 2 min. 1 μL of amplified pro-
duct was then used in a nested 5’RACE reaction target-
ing RNase8 using the nested 3’ ® 5’ R85Rn gene-
specific primer and nested adapter primer. The follow-
ing cycling parameters were used for the nested RACE:
94°C for 1 min followed by 35 cycles of 94°C for 30 sec.
and then 62°C for 2 min. This method yielded two
amplification products, ~0.8 kb and ~1 kb, which were
both cloned into TA 2.1 vectors; multiple clones were
sequenced in both directions using BigDye terminator
v3.1 on a 3130x Applied Biosystems sequencer accord-
ing to manufacturer’s instructions.
Reverse transcriptase polymerase chain reaction (RT-PCR)
detection of RNase 8
Human spleen and placenta poly A
+ RNA (Clontech)
were used to generate cDNA with a 1
st strand cDNA
synthesis kit (Roche) following manufacturer’si n s t r u c -
tions. Briefly, 1 μg of RNA was DNase I-treated (Invitro-
gen) according to manufacturer’s instructions; 100 ng of
DNase-treated poly A
+ RNA was reverse transcribed
into cDNA using the following parameters: 25°C for 10
min, then 42°C for 60 min followed by 99°C for 5 min.,
and finally 4°C for 5 min. Control (no reverse transcrip-
tase (RT)) samples were also generated. PCR amplifica-
tion of RNase8S fragment was performed using cDNA
from human spleen or placenta (or no RT controls),
Titanium Taq polymerase kit, and primers R8S and
R85R with the following cycling parameters: 95°C for 1
min, then 30 cycles of 95°C for 30 sec followed by 68°C
1.5 min., and finally 68°C for 3 min. From the RNase8S
amplification product, nested PCR was performed using
Titanium Taq polymerase and primers R8Sn and R85Rn
which generated a ~544 bp fragment with the following
cycling parameters 95°C for 1 min, 30 cycles, 95°C for
30 sec, 68°C 1.5 min, and 68°C for 3 min. The amplifica-
tion products were cloned into TA 2.1 vector and multi-
ple clones were sequenced in both directions using
BigDye terminator v3.1 on a 3130x Applied Biosystems
sequencer according to manufacturer’s instructions.
Quantitative reverse-transcription polymerase chain
reaction (qPCR) detection of RNase 8 expression in
human tissue
Human and fetal tissue cDNA panels (Clontech) were
screened using TaqMan universal PCR master mix and
ABI 7500 Real Time PCR system according to manufac-
turer’s instructions. The following primer/probe set was
used to detect RNase 8,
primers, RNase 8fx, RNase 8rx; probe, 6FAM-RNase
8-TAMRA. The primer/probe set was specific for RNase
8, and did not detect RNase 7 plasmid DNA (data not
shown). Each of the aforementioned tissue samples was
evaluated in triplicate along with a single no-template
control. qPCR screening by this method was also per-
formed on human spleen and placenta cDNA generated
from poly A
+ RNA following the same procedure. Abso-
lute quantities were determined by interpolation to a
standard curve of 10 to 10
10 copies RNase 8 coding
sequence in the pCR 2.1 vector (Invitrogen), run in
duplicate. Human GAPDH was detected via standard
primer/probe set (Applied Biosystems) with absolute
quantities determined by interpolation to a standard
curve (nucleotides 41-1425 of the human GAPDH cod-
ing sequence, GenBank # NM_002046 cloned into pCR
2.1) run in duplicate.
RNase 8 expression plasmids, transfection and
intracellular staining-flow cytometric analysis
RNase 8 expression constructs CCC3, CCC4 and CCC5
were prepared. CCC3 is a full length 595 bp RNase 8
open reading frame with both distal and proximal trans-
lational start sites and a carboxy-terminal FLAG (Figure
2). CCC4 is shortened 550 bp open reading frame that
includes only the proximal translational start site. CCC5
is identical to CCC3 save for a point mutation that con-
verts the methionine (ATG) in the proximal transla-
tional start site to an isoleucine. These open reading
frames were cloned into the Hind III and Xho I restric-
tion sites of expression plasmid pcDNA3.1 (Invitrogen)
and purified (Origene) for transfection into COS-7 cells.
COS-7 cells (ATCC CRL-1651) were seeded at a density
Chan et al. BMC Genomics 2012, 13:40
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6 cells per well in a six well plate 24 hours
prior to transfection. 1 μg of DNA mixed with Lipofec-
tamine 2000 reagent (Invitrogen) in a 1:3 ratio was
added dropwise to each well. Six hours after addition of
the transfection mixture, fresh media was added. 48
hours post-transfection, cells were removed from the
plate with 0.05% Trypsin (Invitrogen) and 2 × 10
5 cells
w e r ea d d e dt oap o l y s t y r e n et u b e( F a l c o n ) ,f i x e dw i t h
4% paraformaldehyde (Thermo Scientific), and washed 3
times with ice-cold 0.1% PBS/BSA. Cells were then
washed 3 times with 0.1% PBS/Saponin solution and
blocked with 5% milk in 0.1% PBS/saponin for 30 min-
utes on ice. After blocking, cells were stained with either
rabbit anti-FLAG antibody conjugated to Alexa 647
(Cell Signaling) or anti-rabbit conjugated to Alexa 647
(Cell Signaling), both diluted 1:100 in 0.1% PBS/saponin
for 30 minutes on ice. Cells were then washed 3 times
in PBS/BSA 0.1% and one hundred thousand events
were collected using an LSRII flow cytometer (BD Bios-
ciences) and data collected was analyzed by FlowJo
(Tree Star).
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